{"schema_version":"secwatch.filing_event.v1","accession":"0001619856-24-000003","form_type":"8-K","ticker":"CRBU","cik":"0001619856","company_name":"Caribou Biosciences, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.834960+00:00","generated_at":"2026-06-07T02:19:27.631973+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Caribou appoints Tim Kelly as CTO; plans CB-010 pivotal trial by YE 2024, cash into Q4 2025","bullets":["Tim Kelly appointed CTO; previously CEO of Oxford Biomedica Solutions, led technical ops at Sarepta, Shire, and Biogen.","$396.7M cash, cash equivalents, and marketable securities as of Sep 30, 2023; expected runway into Q4 2025.","CB-010: initial dose expansion data from ANTLER trial and RP2D expected Q2 2024; Phase 3 pivotal in 2L LBCL by YE 2024.","CB-011: initial dose escalation data from CaMMouflage trial expected by YE 2024.","CB-012: patient enrollment in AMpLify Phase 1 trial for r/r AML expected to initiate H1 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001619856-24-000003","json":"https://secwatch.observer/filing/0001619856-24-000003.json","markdown":"https://secwatch.observer/filing/0001619856-24-000003.md","text":"https://secwatch.observer/filing/0001619856-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1619856/000161985624000003/0001619856-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1619856/000161985624000003/crbu-20240107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:19:27.631973+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}